Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year

Mantle cell lymphoma (MCL) is an infrequent subtype of non-Hodgkin’s lymphoma (NHL) and represents between 4–8% of adult lymphomas. Recently an increase in its incidence to 1–2 cases/100,000 inhabitants/year has been observed. The first line of treatment is based on chemoimmunotherapy and depends on...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrero-Vicent, Carmen, Machado, Isidro, Illueca, Carmen, Avaria, Amparo, Salazar, Claudia, Hernandez, Abraham, Sandiego, Sergio, Lavernia, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817526/
https://www.ncbi.nlm.nih.gov/pubmed/27110283
http://dx.doi.org/10.3332/ecancer.2016.627
_version_ 1782424906313498624
author Herrero-Vicent, Carmen
Machado, Isidro
Illueca, Carmen
Avaria, Amparo
Salazar, Claudia
Hernandez, Abraham
Sandiego, Sergio
Lavernia, Javier
author_facet Herrero-Vicent, Carmen
Machado, Isidro
Illueca, Carmen
Avaria, Amparo
Salazar, Claudia
Hernandez, Abraham
Sandiego, Sergio
Lavernia, Javier
author_sort Herrero-Vicent, Carmen
collection PubMed
description Mantle cell lymphoma (MCL) is an infrequent subtype of non-Hodgkin’s lymphoma (NHL) and represents between 4–8% of adult lymphomas. Recently an increase in its incidence to 1–2 cases/100,000 inhabitants/year has been observed. The first line of treatment is based on chemoimmunotherapy and depends on age and the initial stage at diagnosis. There are no second line or successive treatments. There are currently several drugs available that provide acceptable results.
format Online
Article
Text
id pubmed-4817526
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-48175262016-04-22 Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year Herrero-Vicent, Carmen Machado, Isidro Illueca, Carmen Avaria, Amparo Salazar, Claudia Hernandez, Abraham Sandiego, Sergio Lavernia, Javier Ecancermedicalscience Clinical Study Mantle cell lymphoma (MCL) is an infrequent subtype of non-Hodgkin’s lymphoma (NHL) and represents between 4–8% of adult lymphomas. Recently an increase in its incidence to 1–2 cases/100,000 inhabitants/year has been observed. The first line of treatment is based on chemoimmunotherapy and depends on age and the initial stage at diagnosis. There are no second line or successive treatments. There are currently several drugs available that provide acceptable results. Cancer Intelligence 2016-03-17 /pmc/articles/PMC4817526/ /pubmed/27110283 http://dx.doi.org/10.3332/ecancer.2016.627 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Herrero-Vicent, Carmen
Machado, Isidro
Illueca, Carmen
Avaria, Amparo
Salazar, Claudia
Hernandez, Abraham
Sandiego, Sergio
Lavernia, Javier
Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
title Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
title_full Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
title_fullStr Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
title_full_unstemmed Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
title_short Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
title_sort diagnostic and therapeutic update of mantle cell lymphoma (mcl): analysis of seven cases treated in a centre in one year
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817526/
https://www.ncbi.nlm.nih.gov/pubmed/27110283
http://dx.doi.org/10.3332/ecancer.2016.627
work_keys_str_mv AT herrerovicentcarmen diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT machadoisidro diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT illuecacarmen diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT avariaamparo diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT salazarclaudia diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT hernandezabraham diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT sandiegosergio diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear
AT laverniajavier diagnosticandtherapeuticupdateofmantlecelllymphomamclanalysisofsevencasestreatedinacentreinoneyear

Ejemplares similares